Beckman Laser Institute

What Beckman Laser Institute does

Beckman Laser Institute & Medical Clinic (BLIMC) is a Special Research Program within the University of California, Irvine, operating as an academic research institute and medical clinic focused on biomedical photonics and laser medicine. Established in 1988 (per organizational history) under the Beckman Foundation initiative, the institute develops optical imaging technologies and laser therapies for diseases that were previously untreatable, with stated global impact on tens of millions of patients. Its core technology platforms include Optical Coherence Tomography (OCT), Laser Speckle Imaging (LSI), Spatial Frequency Domain Imaging (SFDI), Optical Clearing Techniques, and a novel laser-Compton X-ray system (HyperVIEW).

The institute operates a hybrid business model combining federal research grants (NIH, NSF, DARPA, DOD), clinical service revenue from its on-site medical clinic, technology licensing royalties, and philanthropic donations through UC Irvine giving programs. Notable commercialized technologies include the FDA-cleared Ox-Imager CS (SFDI-based, via spin-off Modulim), the multiphoton exoscope for non-invasive melanoma detection, wearable hemodynamic monitoring patches, and a low-cost portable oral cancer screening device deployed in India. The institute runs the Photonic Incubator and Convergence Optical Sciences Initiative (COSI) to support technology commercialization, with active spin-offs including Modulim (SFDI), Lumitron Technologies (laser-Compton X-ray), and Vena Vitals (wearable sensors). It also functions as a training center through programs including ACES, the Multiscale Biophotonics Training Program, and the Leaders in Light conference.

BLIMC serves four primary customer segments: individual patients receiving laser treatments at the medical clinic, academic and clinical researchers utilizing shared biophotonics resources, industry partners licensing technology and engaging through the COSI corporate partner program, and students/trainees across graduate and postdoctoral programs. Dr. Bernard Choi was formally appointed Director in April 2026 following a three-year interim tenure. The institute's revenue and headcount as a standalone entity are not publicly disclosed; the firmographic figure of 5001-10000 employees likely reflects UC Irvine's broader staff rather than BLI specifically, as fewer than a dozen named management team members are identified.

Name

Beckman Laser Institute

Legal name

Beckman Laser Institute & Medical Clinic

Website

https://bli.uci.edu

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Beckman Laser Institute & Medical Clinic is a UC Irvine academic research institute and medical clinic developing biophotonics and laser medicine technologies — including OCT, laser speckle imaging, and laser-Compton X-ray systems — serving patients, researchers, industry partners, and trainees through research, clinical services, and technology licensing.

Ownership category

akta.pro rank

Product category

Biomedical Photonics Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Diagnostic Imaging Centers (621512)

SIC

Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

• Biomedical photonics research
• Laser medicine therapies
• Optical imaging technologies
• Medical device development
• Translational research services

Headquarters

HQ city

Irvine

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Federal Research Grants: Competitive extramural funding from NIH, NSF, DOD, DARPA, and other federal sponsors for research programs
2. Clinical Services: Medical clinic providing patient care services for laser treatments and optical diagnostics
3. Technology Licensing: Revenue from licensing patents and technology to spin-off companies and industry partners
4. Philanthropic Donations: Donations through UC Irvine giving programs supporting research and operations

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Beckman Laser Institute & Medical Clinic operates an integrated biomedical photonics research program and a patient-facing medical clinic that delivers novel laser therapies and optical diagnostics, while commercializing its inventions through technology licensing and spin-off companies. The institute advances optical imaging, laser therapy, and translational biophotonics research, training students, fellows, and physicians, and providing clinical care for referred and direct patients.

Product overview

Beckman Laser Institute & Medical Clinic is a premier research institution focused on biomedical photonics, laser medicine, and translational optical research. The organization operates across multiple research cores including Modeling & Computation, Multimodal Endoscopy, Microscopy & Microbeams, Diffuse Optical Imaging, and Laser Therapy. Key technology platforms include Optical Coherence Tomography (OCT), Laser Speckle Imaging (LSI), Spatial Frequency Domain Imaging (SFDI), and Diffuse Optical Spectroscopy. Notable medical devices include the FDA-cleared Ox-Imager CS, the multiphoton exoscope (FLAME) for melanoma detection, and wearable hemodynamic monitoring systems for hemorrhage detection. The institute also developed a portable oral cancer screening device and conducts research into wearable sensors for maternal-fetal health monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• BLIMC Medical Clinic Patient-facing medical clinic at the Irvine campus delivering laser and optical diagnostic and therapeutic services to referred and direct patients for vascular and pigmented lesions, scars, and other conditions treatable through novel laser medicine.
• Biomedical Photonics Research and Collaboration Services Multi-core research program (Modeling & Computation, Multimodal Endoscopy, Microscopy & Microbeams, Diffuse Optical Imaging, Laser Therapy) plus shared UCI access resources enabling collaborative research with academic and clinical investigators on optical imaging, laser therapy, and translational biophotonics.

Quantifiable outcome

• Tens of millions of patients worldwide benefitting from institute-developed therapies
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• Modulim Inc.coreTechnology or IntegrationSpin-off company commercializing Spatial Frequency Domain Imaging (SFDI) technology; founded by Dr. David Cuccia and Amaan Mazhar from BLIMC research; Ox-Imager CS received FDA clearance for vascular assessment.
• Lumitron Technologies Inc.coreTechnology or IntegrationCo-founded by Dr. Chris Barty; developing HyperVIEW laser-Compton X-ray system for next-generation cancer treatments; received FDA Breakthrough Device designation for breast cancer imaging.
• Vena VitalsmajorTechnology or IntegrationStartup founded based on Michelle Khine's research at BLIMC; developing wearable blood pressure sensor technology; has space at UCI's Cove and University Lab Partners.
• Mazumdar Shaw Cancer Center (India)majorStrategic or Co-development PartnerPartnership with Dr. Petra Wilder-Smith to develop low-cost portable oral cancer screening device for underserved populations in India; screened over 12,000 people.
• Bridge Ventilator ConsortiummajorStrategic or Co-development PartnerCollaboration with University of Texas Austin and Virgin Orbit to develop open-source bridge ventilators during COVID-19 pandemic; design freely available to manufacturers.
• UC Irvine Beall Applied InnovationcoreStrategic or Co-development PartnerSupports technology transfer and commercialization; runs Innovator Awards program recognizing UCI researchers; provides Proof of Product grants and market development support.
• Convergence Optical Sciences Initiative (COSI) Corporate PartnersmajorStrategic or Co-development PartnerIndustry partnership program connecting BLIMC research with corporate partners for technology development and commercialization.
• University Lab PartnersminorStrategic or Co-development PartnerNonprofit wet lab incubator at UCI Research Park providing space for spin-off companies including Vena Vitals.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Wellman Center for Photomedicine: Harvard/Massachusetts General Hospital's premier biomedical photonics and laser medicine research center, the most analogous peer to BLIMC. Both operate translational models integrating biophotonics research with clinical application and pursue FDA-cleared optical diagnostics.
• Modulim: BLIMC spin-off (founded by Dr. David Cuccia and Amaan Mazhar from BLIMC research) commercializing Spatial Frequency Domain Imaging (SFDI) for tissue oxygenation measurement, including the FDA-cleared Ox-Imager CS. Direct commercial extension of BLIMC's SFDI technology.
• Lumitron Technologies: BLIMC spin-off (co-founded by Dr. Chris Barty) developing the HyperVIEW laser-Compton X-ray system, which received FDA Breakthrough Device Designation for breast cancer imaging. Direct commercial extension of BLIMC's laser-Compton technology.
• Vena Vitals: Startup founded on Michelle Khine's BLIMC research, developing wearable optical blood pressure sensing technology. Participated in Y Combinator and MedTech Innovator; serves as a direct example of BLIMC's wearable biophotonics commercialization pathway.

Broad incumbents

• Heidelberg Engineering: Established ophthalmic imaging company specializing in OCT, confocal scanning laser ophthalmoscopy, and other laser-based diagnostic platforms. Comparable as a commercial counterpart to BLIMC's OCT and ocular imaging research programs.
• Carl Zeiss Meditec: Global medical technology division of Zeiss focused on ophthalmic diagnostic and surgical lasers, including OCT systems and laser therapy platforms. Represents the commercial scale BLIMC's translational research targets.
• Hamamatsu Photonics: Japanese photonics company supplying lasers, photodetectors, and optical imaging components used broadly in biomedical research. Comparable as a major photonics platform provider intersecting BLIMC's research supply chain.
• Coherent Corp: Global laser and photonics manufacturer serving medical, biomedical, and industrial markets. Comparable as an incumbent laser systems provider whose products and technology roadmaps intersect BLIMC's laser medicine programs.
• Lumenis: Medical laser company focused on aesthetics, surgical, and ophthalmic laser systems. Comparable as a commercial medical laser platform serving clinical end-users similar to BLIMC's BLIMC medical clinic.

Others

• Thorlabs: Major photonics and laser components supplier serving research labs globally. Comparable as a key enabling supplier to BLIMC's biophotonics research operations rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ucirvine
• YouTubeyoutube.com/channel/UCNfc9YedNnNUsy2wsLU1BLA
• Facebookfacebook.com/ucirvine
• LinkedInlinkedin.com/company/university-of-california-irvine
• Instagraminstagram.com/uci.beckmanlaser

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beckman Laser Institute